SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AXYS Pharmaceuticals Inc.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (453)4/10/2001 5:19:44 AM
From: Mike McFarland  Read Replies (1) of 455
 
A Novel Serine Protease Inhibition Motif Involving a Multi-centered Short Hydrogen Bonding Network at the Active Site

Sounds impressive.
Doesn't make me feel much better about what
I paid for my shares--which have traded as
low as $2 1/4 recently.

I think it was Tuck who pointed to the DPII slides.
"155 proprietary chemical scaffolds"
Useing a Beowulf computer for data mining
(isn't that just a network of PCs running Linux?)
Well, sounds cool. Have to say though, the Aurora
presentation at H&Q was much more upbeat--market
conditions probably effect these guys at least as
much as us.

I loved this:
Surely the naive and the perplexed can be forgiven for their enthusiasm about what this industry is capable of in the next 25 years.
redherring.com

Oh, so glad RedHerring is offering absolution.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News